Inhibitors of the α2β1/GPIa-IIa integrin
US8258159B2 · kind B2 · utility
3Cited by
8References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 2006 |
| Grant date | Sep 4, 2012 |
| Priority date | — |
| Expiry date | Aug 25, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/06165
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds inhibiting the integrin α2β1/GPIa-IIa receptor are disclosed. Also disclosed are pharmaceutical compositions containing the compounds, as well as methods of their therapeutic use. The compounds disclosed are useful, inter alia, as inhibitors of integrin α2β1/GPIa-IIa-mediated activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.